IART Integra Lifesciences Holdings · $19.25 Extended — don't chase; wait for a pullback过度拉升 — 勿追高;等待回撤 Terminal终端
Integra Lifesciences Holdings · Health Care

IART

$19.25
Integra LifeSciences Holdings Corporation is a global medical device manufacturing company headquartered in Princeton, New Jersey. Founded in 1989, the company manufactures products for skin regeneration, neurosurgery, reconstructive and general surgery.IntegraLifeSciencesHoldingsCorporation是一家全球医疗设备制造公司,总部位于新泽西州普林斯顿,成立于1989年,生产用于皮肤再生、神经外科、重建和普通外科的产品。
Speculative / unprofitable投机/未盈利 Small cap小盘 $2B
Engine stance引擎立场2026-07-20
Extended — don't chase; wait for a pullback过度拉升 — 勿追高;等待回撤
You missed the bottoming entry — the low already formed and price is now extended (overbought (daily RSI 62, 3-day 74 & 已错过筑底入场——低点已经形成,目前价格已拉伸(已超买(日线 RSI 62、3 日 74 与周线 72))。不要追高;等待回调至 10 日均线或下一个周期低点。若已持有则继续持有。
Open in Terminal打开终端 All coverage所有股票 Data through数据截至 2026-07-20 · regenerated nightly每日更新

Key Statistics关键统计

Price价格
$19.25
3.0% below 52-week high低于52周高点 3.0%
Market Cap市值
$2B
Normal volume正常成交量
Beta贝塔
1.94
Moves about 1.9x the market波动幅度约为市场的 1.9 倍
RSI (14)RSI(14)
62
Elevated偏高
Next Earnings下次财报
2026-07-30 (11d)
Volatility Rank波动率分位
21th pctile
hist. vol. percentile历史波动率分位数
Short Interest空头兴趣
8.2% of float

Performance价格表现

Period周期 IART S&P 500vs Index对比指数
1 Week近1周 +2.4% -1.5% Beat the index by 3.9 points跑赢指数 3.9 个百分点
1 Month近1月 +11.9% +0.6% Beat the index by 11.3 points跑赢指数 11.3 个百分点
3 Months近3月 +72.8% +4.7% Beat the index by 68.1 points跑赢指数 68.1 个百分点
6 Months近6月 +55.1% +7.8% Beat the index by 47.3 points跑赢指数 47.3 个百分点
Year to date年初至今 +60.3% +9.1% Beat the index by 51.2 points跑赢指数 51.2 个百分点
1 Year近1年 +60.7% +19.4% Beat the index by 41.3 points跑赢指数 41.3 个百分点
3 Years近3年 -55.9% +69.4% Lagged the index by 125.3 points落后指数 125.3 个百分点

Technicals技术面

RSI (14)RSI(14) 62 Elevated偏高
vs 50-day相对50日均线 +15.1% vs 50-day avg
vs 200-day相对200日均线 +46.8% vs 200-day avg
Volatility rank波动率分位 21th percentile 分位
Engine reference levels — not advice引擎参考水平 — 非投资建议
Buy zone买入区间
$18.38
Don't chase above不追高于
$19.25
Stop止损
$17.20
Topping — protect gains见顶 — 保护利润

Earnings财务业绩

11
days until next report天后公布财报
2026-07-30

Estimates being raised — 2 analysts预期上调 — 2 位分析师

Earnings call transcripts — coming soon财报电话会议记录 — 即将上线

Valuation估值

Multiple指标 IART Sector median行业中位 Cheaper than相对便宜
P/B市净率 1.44x 3.52
89%
P/S市销率 0.92x 3.02
84%
Earnings yield盈利收益率 -34.47% 2.72
4%
FCF yield自由现金流收益率 -2.07% 3.94
9%
Shareholder yield股东收益率 0.01% 1.89
12%
Analyst price targets — coming soon分析师目标价 — 即将上线

Financials财务数据

Revenue营业收入
$1.4B
2020
$1.5B
2021
$1.6B
2022
$1.5B
2023
$1.6B
2024
$1.6B
2025
5yr CAGR5年复合增速: 3.6%
Earnings Per Share每股收益
$1.57
2020
$1.98
2021
$2.16
2022
$0.84
2023
$-0.09
2024
$-6.74
2025
Free Cash Flow自由现金流
$164.9M
2020
$264.4M
2021
$222.1M
2022
$73.1M
2023
$25.0M
2024
-$31.1M
2025
Margins利润率
Operating margin营业利润率
-30.2%
Net margin净利率
-31.6%
FCF margin自由现金流利润率
3.1%
-49.5%Return on Equity股本回报率
-14.3%Return on Assets资产回报率
Leverage杠杆
Current ratio流动比率2.54
Capital Allocation资本配置
Stock-based comp股权薪酬$18.6M
Share count change (1y)股数变化(1年)+0.9%
Piotroski皮奥特罗斯基 4/8 Altman Z阿尔特曼Z: distress (0.8) Warning警示

Snapshot Gauges综合指标

Valuation vs Sector估值相对行业
Looks cheap vs sector相对行业偏便宜
Cheaper than 61% of its sector on blended multiples综合估值倍数低于行业内 61% 的公司
Beta市场敏感度
1.94×
0.2
Moves about 1.9× the market波动幅度约为市场的 1.9 倍
Financial Health财务健康
4/8
Altman阿尔特曼: distress
Weak financial health财务健康状况偏弱
Dividend分红
Does not pay a dividend不派发股息

Why Is It Moving为何波动

Macro宏观 Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓 Short interest changed -11.4%空头仓位变动 -11.4%
Technical技术面 IART daily MACD crossed upIART 日线MACD上穿

Ownership & Smart Money持仓与聪明钱

Insider activity内部人员活动: +$0.1M net (1 buyers, 0 sellers)+$0.1M 净值(1 买家,0 卖家)

Signal History信号历史

BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS. A daily bottoming setup did fire (swing low in, momentum turned up), but it's LATE — price is already extended above the cycle low (formed ~20 day(s) ago @ 17.2) and overbought (daily RSI 62, 3-day 74 & weekly 72). A momentum cross is a LAGGING confirmation: after a vertical run it only triggers once the move is mature, so the bottoming entry has already passed. This is a chase, not a fresh buy止盈。日线筑底形态确实已经触发(摆动低点出现、动量转向上行),但为时已晚——价格已显著高于周期低点(约 20 天前形成 @ 17.2)且已超买(日线 RSI 62、3 日 74 与周线 72)。动量交叉属于滞后确认:在垂直拉升之后,只有当走势已经成熟时才会触发,因此筑底入场早已错过。这是追高,而非新的买入
TOP WATCH NEARING A HIGH
Jul 16, 2026
IART daily MACD crossed upIART 日线MACD上穿
The daily MACD histogram turned positive — fast and noisy, context rather than a standalone trigger. $19.85.日线MACD柱状图转正 — 快速且嘈杂,仅作背景。$19.85。
Jul 15, 2026
IART made a new 52-week highIART 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $18.78.价格创出52周新高 — 全市场关注的动量/趋势极值。$18.78。
Jul 13, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Jul 10, 2026
IART made a new 52-week highIART 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $18.79.价格创出52周新高 — 全市场关注的动量/趋势极值。$18.79。
Jul 10, 2026
IART StochRSI turned up from oversoldIART StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $18.79.StochRSI重回20上方 — 下行动量趋缓的最早预警。$18.79。
Jul 9, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Jul 9, 2026
IART took relative-strength leadershipIART 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $18.39.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$18.39。
Jul 7, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Jul 2, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈

Showing last 15 of显示最近15条,共 241 signals条信号

Factor Profile因子特征

Composite factor score综合因子得分: -0.41
Value价值
-1.6
Quality质量
+0.9
Investment资本投入
+1.1
Shareholder payout股东回报
-1.0
Low volatility低波动
-1.5
Low market beta低市场敏感度
-1.4
Earnings quality盈利质量
+1.7
Short interest空头兴趣
-0.8

Company Profile公司档案

Integra LifeSciences Holdings Corporation is a global medical device manufacturing company headquartered in Princeton, New Jersey. Founded in 1989, the company manufactures products for skin regeneration, neurosurgery, reconstructive and general surgery.IntegraLifeSciencesHoldingsCorporation是一家全球医疗设备制造公司,总部位于新泽西州普林斯顿,成立于1989年,生产用于皮肤再生、神经外科、重建和普通外科的产品。
Get the full picture获取完整视图
Nightly signals, options flow, and factor analysis across all S&P 500 names.每日更新的信号、期权资金流向和因子分析,覆盖所有标普500成分股。